Skip to main content
. Author manuscript; available in PMC: 2012 Dec 10.
Published in final edited form as: Gynecol Oncol. 2011 Aug 3;123(2):320–328. doi: 10.1016/j.ygyno.2011.07.005

Figure 2.

Figure 2

Figure 2

Figure 2

Figure 2

Figure 2

Forest plots for catenins, cadherins and cell cycle regulators in tumor epithelium (E) and stroma (S) for progression-free survival [A] or overall survival [B] with hazard ratios (HR) and 95% confidence intervals (CI) based on Cox models with an adjustment for patient age at study enrollment and stratification for performance status and tumor grade. When the 95% CI does not overlaps a HR of 1.0 (center line), the association was significant. Biomarkers were categorized into tertiles (T1-lowest tertile, T2-middle tertile, T3-highest tertile) for E-cadherinE, N-cadherinE, alpha-cateninE, beta-cateninE, gamma-cateninE, p120-cateninE and Ki-67E; as negative, below median or above median for p16E, p27E and CD44S; or as negative or positive for p53E, Ki-67S and APCS. Kaplan-Meier survival distributions provided for tumor epithelial expression of E-cadherinE [C], p16E [D], or p53E [E]. Logrank test was used to test the equality in the survival distributions [C–E]. Significant associations (p<0.05) with survival were observed for E-cadherinE [C], p16E [D], or p53E [E]. Death is the event and censored indicates patients who were alive at last contact [C-E]. Median survival times are provided in months with 95% CI.